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Introduction
The adhesion of lymphocytes to vascular endothelium, extra-
cellular matrix, and antigen-presenting cells (APCs) is critical 
to adaptive immunity and must be tightly regulated. Control of 
lymphocyte adhesion is accomplished, in large part, through the 
regulation of the principle adhesion molecule on the lymphocyte 
surface, the 2 integrin designated lymphocyte functional anti-
gen 1 (LFA-1; Dustin et al., 2004). LFA-1 binds to intercellular 
adhesion molecule 1 (ICAM-1) on the surface of endothelium 
and APCs. Like other integrins, LFA-1 is an / heterodimeric 
transmembrane receptor that exists in multiple affinity states. 
The most adhesive state is thought to result from a conforma-
tional change in the receptor that extends the ectodomains of 
the  and  chains and is controlled by the disposition of the 
cytosolic domains (Schürpf and Springer, 2011). Talin, an actin 
binding protein, has been shown to interact with the  chain via 
its FERM domain and thereby activate integrins (Calderwood 
et al., 1999). Recruitment of talin is thought to represent the   
final step in signaling events within the lymphocyte that impinge 
on the cytosolic domains of the integrin, resulting in reorienta-
tion and enhanced adhesion of the ectodomains. This process is 
referred to as inside-out signaling (Kim et al., 2003; Mor et al., 
2007) because most receptors on the cell surface convey infor-
mation in the opposite direction.
The identity and mechanisms of action of the molecular 
components  of  inside-out  signaling  through  LFA-1  is  an 
intensely studied area. Among the few signaling molecules that 
have been implicated in the regulation of this process is Rap1, a 
small GTPase closely related to Ras. Expression of constitutively 
active Rap1 in lymphocytes induces LFA-1–mediated adhesion 
(Reedquist et al., 2000), and silencing (Ebisuno et al., 2010; 
Lafuente et al., 2004) or knockout (Duchniewicz et al., 2006) of 
Rap1a diminishes adhesion. Because small GTPases invariably 
A
daptive immunity depends on lymphocyte adhe-
sion that is mediated by the integrin lymphocyte 
functional antigen 1 (LFA-1). The small guano-
sine triphosphatase Rap1 regulates LFA-1 adhesiveness 
through one of its effectors, Rap1-interacting adapter 
molecule (RIAM). We show that RIAM was recruited to 
the lymphocyte plasma membrane (PM) through its Ras 
association (RA) and pleckstrin homology (PH) domains, 
both of which were required for lymphocyte adhesion. 
The N terminus of RIAM inhibited membrane transloca-
tion. In vitro, the RA domain bound both Rap1 and H-Ras 
with equal but relatively low affinity, whereas in vivo only 
Rap1 was required for PM association. The PH domain 
bound phosphoinositol 4,5-bisphosphate (PI(4,5)P2) and 
was responsible for the spatial distribution of RIAM only 
at the PM of activated T cells. We determined the crys-
tal structure of the RA and PH domains and found that, 
despite an intervening linker of 50 aa, the two domains 
were integrated into a single structural unit, which was 
critical for proper localization to the PM. Thus, the RA-PH 
domains of RIAM function as a proximity detector for ac-
tivated Rap1 and PI(4,5)P2.
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In contrast, the RA-PH domains expressed together with their 
endogenous linker but without the N and C terminus of RIAM 
(GFP-RA-PH) colocalized efficiently with mCherry-Rap1V12 
at the PM (Fig. 1 A).
The inability to detect translocation of full-length, over-
expressed GFP-RIAM to the PM by live cell imaging is con-
cordant with results reported for other multidomain signaling 
proteins (Bondeva et al., 2002; Gureasko et al., 2008) and 
may relate to the relatively small fraction of the protein that 
interacts stably with the PM. To determine if endogenous 
RIAM translocates to the PM upon stimulation of Jurkat cells 
through the T cell receptor (TCR), we used nitrogen cavitation, 
subcellular fractionation, and immunoblot analysis (Fig. 1 B).   
Whereas all immunodetectable Rap1 was found in the mem-
brane fraction, with or without stimulation, we found that the 
portion  of  endogenous  RIAM  detected  in  the  membrane 
was small but increased from 1.7 ± 0.7 to 3.5 ± 0.2% (n = 3,   
P < 0.02) after stimulation. Thus, <2% of the total pool trans-
located. This result establishes that full-length RIAM does 
indeed translocate to membranes and also explains why it is 
difficult to detect translocation of overexpressed GFP-RIAM 
by imaging.
Strikingly, no colocalization of mCherry-Rap1V12 and 
GFP-RA-PH was observed on internal membranes. To deter-
mine if mCherry-Rap1V12 on internal membranes is accessible 
to probes that incorporate an efficient Rap1 binding domain, we 
also coexpressed mCherry-Rap1V12 with GFP-RalGDS-RBD 
(Ras binding domain) and observed efficient colocalization on 
all membranes decorated with mCherry-Rap1V12 (Fig. 1 A). 
These data indicate that expression of active Rap1 is sufficient 
to recruit GFP-RA-PH to the PM but not to internal membranes, 
and they suggest that translocation to the PM requires an ad-
ditional determinant.
To determine if the RA-PH domains of RIAM are also re-
stricted to the PM after physiological stimulation of lympho-
cytes through the TCR, we coexpressed in Jurkat T cells the 
GFP-RA-PH probe with wild-type Rap1 tagged with mCherry 
(Fig. 1 C). mCherry-Rap1 was distributed in a pattern indistin-
guishable from that of activated mCherry-Rap1V12 on both 
PM and internal membranes. In serum-starved Jurkat cells 
coexpressing  mCherry-Rap1,  GFP-RA-PH  was  expressed 
in the cytosol without decoration of any membrane. Within   
2 min of stimulation with anti-CD3 antibodies, GFP-RA-PH 
translocated from the cytosol to the PM but not to endomem-
branes (Fig. 1 C). To verify that wild-type Rap1 becomes 
loaded with GTP on both the PM and internal membranes 
in response to stimulation, we used GFP-RalGDS-RBD as 
a probe for GTP-bound Rap1 and observed translocation to 
both the PM and internal membranes in response to cross-
linking TCRs (Fig. 1 D). Thus, as was the case for expres-
sion of constitutively active Rap1, physiological stimulation 
of T cells through the TCR also led to activation of Rap1 
on multiple membrane compartments but membrane recruit-
ment of GFP-RA-PH was restricted to the PM.
To determine if the pattern of translocation of GFP-RA-PH 
is specific to lymphocytes, we performed an analogous experiment 
in COS-1 fibroblasts and found that, although mCherry-Rap1 was 
signal through effector molecules that bind to the GTPase only 
when it is GTP bound, there has been considerable interest in 
proteins that bind to GTP-loaded Rap1 in hematopoietic cells. 
Two such effectors have been identified using yeast two-hybrid 
screens. The first, RapL, was shown to regulate the clustering of 
LFA-1 at the leading edge of lymphocytes and at the immuno-
logical synapse (Katagiri et al., 2003), and RapL deficiency 
impairs lymphocyte adhesion and homing to secondary lym-
phoid organs (Katagiri et al., 2004). The second effector is Rap1-
interacting adapter molecule (RIAM; Lafuente et al., 2004).
Overexpression of RIAM enhances lymphocyte adhe-
sion, and silencing of RIAM inhibits Rap1-mediated LFA-1 
activation (Lafuente et al., 2004). Moreover, the N-terminal 
region of RIAM binds talin (Lee et al., 2009). RIAM is a 
multidomain protein that includes a talin binding region, two 
coiled-coiled regions, two proline-rich regions, and sequen-
tial Ras association (RA) and pleckstrin homology (PH) do-
mains (Fig. 2 A; Lafuente et al., 2004). The tandem RA-PH 
domains place RIAM in a family of proteins that also in-
cludes MIG-10, lamellipodin, and Pico, the so-called MRL 
family (Mig-10/RIAM/lamellipodin; Lafuente et al., 2004; 
Holt and Daly, 2005), which are related by the tandem RA-
PH domains to the adaptor proteins Grb7/10/14. Because RA 
domains bind activated Ras-family GTPases that are associ-
ated with membranes and PH domains bind phosphoinositide 
phosphates (PIPs), which are constituents of the inner leaflet of 
the plasma membrane (PM), the RA-PH domains are consid-
ered to be a membrane-association module. Because RIAM 
must associate with the PM to regulate LFA-1, the function 
of the RA-PH domains should be critical to LFA-1 activation 
and therefore lymphocyte biology.
We have characterized the biochemical and structural fea-
tures of the RA-PH domains that control the association of RIAM 
with the PM. Although the RA domain binds to both GTP-bound 
Rap1 and Ras in vitro with similar affinities, only Rap1 controls 
RIAM  translocation  in  intact  cells.  The  PH  domain  binds  to 
PI(4,5)P2. Both Rap1 and PI(4,5)P2 binding are relatively low af-
finity, which explains why both are required for RIAM transloca-
tion. We determined the crystal structure of the RIAM RA-PH 
domains, which revealed that these two domains form a single 
structural entity that is critical for its function. Thus, the integrated 
RA-PH structure of RIAM acts as an AND gate to integrate Rap1 
activation and PI(4,5)P2 concentrations and as a proximity detector 
that restricts RIAM localization to the PM of activated cells.
Results
RIAM translocation to the PM in living cells
To study the ability of Rap1 to induce RIAM translocation   
to the PM in living cells, we tagged RIAM, or fragments 
thereof, with GFP and coexpressed these in Jurkat T cells with 
constitutively active mCherry-Rap1V12 (Fig. 1 A). As ex-
pected, mCherry-Rap1V12 was expressed both on the PM 
and internal membranes including the nuclear envelope. Nei-
ther full-length RIAM nor the RA domain expressed alone 
colocalized with mCherry-Rap1V12 but instead remained in 
the cytoplasm without decorating any membrane compartment. 319 Membrane association of RIAM • Wynne et al.
not responsible for the inhibition. Whereas RIAM lacking 
its C terminus (RIAM CT) behaved like full-length RIAM 
and  could  not  be  recruited  by  mCherry-Rap1V12,  RIAM 
lacking its N terminus (RIAM NT) was recruited to the   
PM like GFP-RA-PH (Fig. 2 C). Thus, the RIAM N terminus   
inhibits the ability of the RA-PH domains to bind to the PM. 
Further analysis with additional truncation mutants (Fig. 2 C) 
mapped an inhibitory region to aa 29–57, which link the   
N-terminal talin binding region (aa 1–30) and the first of two 
N-terminal coiled-coil regions (aa 62–89). However, excision 
of aa 29–56 resulted in a construct that could not translocate 
to the PM, suggesting that, assuming proper folding of the 
domains flanking the deletion, the talin-binding domain is 
also inhibitory. These data suggest that the N-terminal region 
of RIAM, with or without the adjacent coiled-coil domain, 
might contribute to an intra- or intermolecular interaction 
that autoinhibits the molecule by blocking access to binding 
determinants at the PM.
expressed on both the PM and internal membrane of serum-starved 
cells, EGF stimulated GFP-RA-PH translocation only to the PM 
(Fig. 1 E). Together, these data show that although Rap1 is acti-
vated on multiple cellular membranes, the recruitment of its   
effector RIAM is restricted to the PM.
Autoinhibition by an N-terminal  
coiled-coil region
The  markedly  higher  affinity  of  GFP-RA-PH  relative  to 
full-length GFP-RIAM for the PM of cells expressing GTP-
bound Rap1 suggests that RA-PH is an efficient membrane 
targeting module that is inhibited by other regions of RIAM. 
To determine what portion of RIAM is responsible for inhib-
iting the translocation of full-length RIAM to the PM, we   
performed an analysis using a series of GFP-tagged dele-
tion mutants (Fig. 2 A). Neither RIAM-GFP (Fig. 2 B) nor 
GFP-RIAM  (Fig.  2  C)  could  be  recruited  to  the  PM  by 
mCherry-Rap1V12 expression, indicating that the GFP tag was 
Figure 1.  RIAM translocation to the PM in live cells. (A) GFP-tagged full-length (FL) RIAM, RIAM RA domain, RIAM RA-PH domains, or RalGDS-RBD (positive 
control probe for GTP-bound Rap1) were coexpressed in Jurkat T cells along with mCherry-tagged constitutively active Rap1V12 and the cells were imaged 
with a laser-scanning confocal microscope 24 h later. (B) Jurkat cells were homogenized by nitrogen cavitation before and after stimulation with anti-CD3 
antibodies and membrane and cytosolic fractions were blotted for RIAM and RhoGDI (cytosolic control). Blots were quantified by Li-Cor and percent RIAM 
in the membrane fraction is indicated (n = 3, P < 0.02). (C and D) GFP-RA-PH (C) or GFP-RalGDS-RBD (D) was coexpressed with mCherry-tagged wild-type 
Rap1 in Jurkat T cells that were serum starved for 2 h and then imaged before and at the indicated times after the addition of cross-linking antibodies to CD3 
(100 ng/ml). (E) The same experiment as in B substituting serum-starved COS-1 fibroblasts stimulated with 50 ng/ml EGF for the Jurkat T cells. Bars: (Jurkat 
cells) 5 µm; (COS-1 cells) 10 µm. Confocal images are representative of >80% of at least 20 cells imaged in at least three independent experiments.JCB • VOLUME 199 • NUMBER 2 • 2012   320
that the recombinant Rap1 was properly folded and capable   
of activation upon GTP binding (Fig. 3 A). GTP dependence was 
also observed with affinity capture of GFP-RA-PH. However, 
efficient pulldown of this protein was only achieved with 4 µM 
GST-Rap1 loaded with GTPS (Fig. 3 A). Thus, although the 
RA domain of RIAM interacts in vitro with GTP-loaded Rap1, 
it does so with an affinity that is at least an order of magnitude 
less than that for binding to the RBD of RalGDS. GFP-RA-PH 
could also be affinity-purified to a similar extent by 4 µM GST-
H-Ras loaded with GTPS (Fig. 3 B). Full-length GFP-RIAM 
also bound to 4 µM GTP-loaded Rap1 and H-Ras, but to a much 
lesser degree than did GFP-RA-PH (Fig. 3 B). Importantly, 
Low affinity binding of the RA domain  
to activated Rap1
To study in vitro the interaction of RIAM with Rap1, we ex-
pressed GST-Rap1 in Escherichia coli, purified the fusion pro-
tein, loaded it with either GDPS or GTPS, and attempted 
affinity purification of GFP-RIAM or GFP-RA-PH from the   
lysate of COS-1 cells expressing the GFP-tagged proteins (Fig. 3, 
A and B). As a control, we expressed GFP-RalGDS-RBD, 
which is known to bind with high affinity to GTP-bound Rap1 
(Bivona et al., 2004). GFP-RalGDS-RBD was affinity purified 
efficiently by 200 nM GST-Rap1 loaded with GTPS. GTP- 
dependence was observed even at 4 µM GST-Rap1, demonstrating 
Figure 2.  The N terminus of RIAM inhibits translocation to 
the PM. (A) The domain structure of RIAM includes a talin 
binding (TB) region, two coiled-coil (CC) regions, short and 
long polyproline (PP) regions, and the membrane targeting 
region consisting of RA and PH domains. The truncation 
mutants produced to analyze membrane association are 
aligned with full-length RIAM. (B) Co-expression of RIAM-
GFP, tagged at the opposite end relative to GFP-RIAM, with 
constitutively  active  mCherry-Rap1V12  in  Jurkat  T  cells.   
(C) Co-expression of GFP-RIAM or the indicated truncations 
with mCherry-Rap1V12 in Jurkat T cells. Bars: 5 µm.321 Membrane association of RIAM • Wynne et al.
Figure 3.  RIAM RA domain binding to Rap1 is required for PM recruitment. (A) Affinity purification of GFP-tagged RIAM RA-PH or RalGDS-RBD by the in-
dicated concentrations of GST-tagged recombinant Rap1b loaded in vitro with either GDPS or GTPS. GFP fusion proteins were visualized by immunoblot 
for GFP. Immunoblots of the inputs are shown to the left. In the bottom panel, the input (lane 1) was run on a separate gel. The positions of the 55 or 43 kD 
markers are indicated for each gel. (B) Protein interaction assay as in A, tracking affinity purification of GFP-RIAM, GFP-RA-PH, and GFP-RA-PH K213A by 
4 µM GDPS- or GTPS-loaded H-Ras or Rap1a. (A and B) the tiff images acquired with the Licor Odyssey were adjusted in Photoshop using the nonlinear 
Levels command. (C and E) Confocal localization of GFP-RA-PH with a K213A substitution predicted to inhibit RA function coexpressed with constitutively 
active mCherry-Rap1V12 in Jurkat T cells (C) or COS-1 cells (E). (D and F) Confocal localization of GFP-RA-PH coexpressed with wild-type mCherry-Rap1 
in anti-CD3-stimulated Jurkat T cells (D) or EGF-stimulated COS-1 cells (F). (G) CFP-tagged dominant negative Hras17N, a potent and specific inhibitor of 
Ras signaling, was coexpressed in serum-starved COS-1 cells with GFP-RA-PH and mCherry-Rap1a and the cells were imaged before and after addition of 
EGF. (H) FLAG-Rap1GAP, a potent and specific inhibitor of Rap signaling, was coexpressed in serum-starved COS-1 cells with GFP-RA-PH and mCherry-
Rap1 and the cells were imaged before and after addition of EGF. Bars: (Jurkat cells) 5 µm; (COS-1 cells) 10 µm.JCB • VOLUME 199 • NUMBER 2 • 2012   322
Figure 4.  RIAM PH domain binds PI(4,5)P2. (A) Colocalization in Jurkat T cells of mCherry-Rap1V12 and GFP-RA-PH with substitutions at the indicated 
basic amino acids that are predicted to be required for PIP binding. AAA indicates the triple mutation of K227A, K331A, and R333A. (B) Fluorescence po-
larization (FP) analysis of the binding of the indicated fluorescently labeled PIPs to recombinant RIAM RA-PH. Kd values obtained from the curve fittings are 
given on the right. As a result of the large protein demands of this experiment, it was performed once, although seven concentrations of RIAM RA-PH were 
measured independently for each PIP. (C) Effect of Wortmannin on Akt phosphorylation and GFP-RA-PH recruitment to PM in a Jurkat T cells coexpressing 
mCherry-Rap1V12. The tiffs shown in the immunoblot were adjusted in Photoshop with the nonlinear Levels command. The nearest molecular mass marker 
is shown to the left. (D) Localization of the PI(4,5)P2 probe, PH-PLC-GFP, or GFP-RA-PH in COS-1 cells coexpressing Rap1V12, an FRB domain tethered 
to the PM, and a cytosolic PI(4,5)P2-directed 5-phosphatase fused with FKBP12, before and after addition of rapamycin to induce heterodimerization of 
FKBP12 and FRB. (E) Localization of PH-PLC-GFP or GFP-RA-PH in COS-1 cells coexpressing mCherry-Rap1V12 and a Gq/PLC linked angiotensin II 
receptor before and after addition of angiotensin II. Bars: (Jurkat cells) 5 µm; (COS-1 cells) 10 µm.323 Membrane association of RIAM • Wynne et al.
when Lys213 in the Rap1 binding domain of GFP-RA-PH was 
mutated to alanine, a mutation predicted to disrupt the GTPase 
binding capacity of the RA domain (Kiel et al., 2005; Wohlgemuth 
et al., 2005), binding to both Rap1 and H-Ras was lost (Fig. 3 B). 
These data reveal that the RA domain binds GTP-bound Rap1, 
but at relatively low affinity, and that the binding activity is   
obtunded in full-length RIAM. The data also reveal that the   
RA domain of RIAM is potentially promiscuous with regard to 
Ras family GTPases because it binds equally well to Rap1 or 
H-Ras in vitro.
To  confirm  these  biochemical  findings  in  living  cells, 
we studied the translocation of GFP-RA-PH in Jurkat T cells. 
The K213A substitution blocked translocation of GFP-RA-PH, 
both as a consequence of coexpression with mCherry-Rap1V12 
(Fig. 3 C) and in response to TCR stimulation (Fig. 3 D).   
A similar effect was observed in COS-1 cells either expressing 
mCherry-Rap1V12 (Fig. 3 E) or wild-type mCherry-Rap1 and 
stimulated with EGF (Fig. 3 F).
Because in vitro H-Ras could substitute for Rap1 in 
RIAM  RA-PH  binding,  we  sought  to  determine  which  of 
these GTPases is relevant to RIAM translocation in living 
cells. The most effective way of shutting down Ras signaling 
without affecting Rap1 is to overexpress dominant-negative 
H-RasN17 (Stacey et al., 1991). Overexpression of H-RasN17 
had  no  effect  on  the  ability  of  mCherry-Rap1–expressing 
COS-1 cells to recruit GFP-RA-PH to the PM in response to 
EGF (Fig. 3 G), suggesting that Ras activation is not required 
for RIAM recruitment. In contrast, overexpression of Rap1GAP,   
a potent and specific negative regulator of Rap1, completely 
blocked  translocation  (Fig.  3  H). These  data  suggest  that 
Rap1 but not Ras activation is required for RIAM transloca-
tion and strongly implicate Rap1 in the physiological regula-
tion of this effector protein.
Low affinity binding of the PH domain  
to PI(4,5)P2
Having implicated the RA domain and Rap1 in RIAM translo-
cation to the PM, we next analyzed the contribution of the PH 
domain. The amino acid sequence in the 1-2 loop region (see 
Crystal structure of the RIAM RA-PH domains) of the PH do-
main of RIAM conforms to the consensus K-Xn-(K/R)-X-R se-
quence (where X is any amino acid), which is associated with 
PIP binding (Isakoff et al., 1998). Mutation of K331 or R333 to 
alanine within this sequence resulted in diminished GFP-RA-PH 
recruitment to the PM in mCherry-Rap1V12–expressing cells, 
and mutation of both of these residues in combination with 
K327 completely abrogated translocation (Fig. 4 A).
Using various fluorescently labeled PIPs, recombinant 
RIAM RA-PH, and fluorescence polarization, we measured 
the binding of PIPs to the protein. No PIP bound with high 
affinity but several bound in the 16–38 µM range. Of these, 
PI(3,4,5)P3 bound best (Kd = 16 µM), although PI5P, PI(4,5)P2, 
and PI(3,4)P2 bound nearly as well with Kd values = 27–38 µM 
(Fig. 4 B). Although Wortmannin inhibited Akt phosphoryla-
tion in TCR-stimulated Jurkat T cells, it had no effect on the 
translocation of GFP-RA-PH to the PM (Fig. 4 C), suggesting 
that PI3K activity is not necessary and that the marginally 
stronger interaction of RA-PH with (the scarce) PI(3,4,5)P3 
has no physiological relevance. PI(4,5)P2 is present in the 
PM at much higher concentrations than PI5P or PI(3,4)P2 
(Lemmon, 2008), making this PIP the most likely physiolog-
ical target for the RIAM PH domain.
To investigate the relevance of PI(4,5)P2, we used a fluo-
rescent biosensor for this PIP, PH-PLC-GFP, an enzyme which 
degrades PI(4,5)P2 and the FKBP12/rapamycin/FRB-induced 
protein dimerization methodology (Fig. 4 D). We expressed the 
catalytic domain of a PI(4,5)P2-directed 5-phosphatase fused 
with both RFP and FKBP12 in cells that also expressed the FRB 
rapamycin binding domain of mTor at the PM (Varnai et al., 
2006). In untreated cells, PH-PLC-GFP decorated the PM in-
dicating that, as expected, this is a compartment enriched in 
PI(4,5)P2. Addition of rapamycin induced rapid (<2 min) loss of 
PH-PLC-GFP from the PM, indicating that the induced dimer-
ization system worked to rapidly dephosphorylate PI(4,5)P2. 
Under the same conditions, GFP-RA-PH was lost from the PM, 
indicating that PI(4,5)P2 is a physiologically relevant ligand for 
the RIAM PH domain. We confirmed this observation by engi-
neering COS-1 cells to express angiotensin II receptors. This 
receptor engages G proteins that are coupled to PLC, which 
also catabolizes PI(4,5)P2 (Várnai and Balla, 1998). Addition of 
angiotensin II to these cells induced a rapid loss of PH-PLC-
GFP from the PM and blocked the recruitment of GFP-RA-PH 
to the PM (Fig. 4 E). Together, these data indicate that the PH 
domain of RIAM is functional, is required for binding to the 
PM, and binds PI(4,5)P2 at this location.
Figure 5.  Functional RA and PH domains are required for adhesion.  
Jurkat T cells were electroporated with the indicated constructs and allowed 
to recover for 48 h. Cells were fluorescently labeled with BCECF, treated 
with or without 5 µg/ml anti-CD3 or 100 ng/ml PMA for 30 min at 37°C 
and allowed to adhere to ICAM-1–coated wells. After gentle washing of 
nonadherent cells, percent adhesion was determined by comparing input 
fluorescence to remaining fluorescence. Data shown are mean ± SEM, n = 3   
(*, P < 0.02; **, P < 0.0005). The immunoblot in the lower panel shows 
equivalent expression of each RIAM construct. The nearest molecular mass 
marker is shown to the left.JCB • VOLUME 199 • NUMBER 2 • 2012   324
T cells to ICAM-1–coated plates and significantly increased   
adhesion after stimulation of the TCR (Fig. 5). In contrast,   
neither the K213A RA domain mutant nor the K327,331,333A 
(AAA) PH domain mutant supported increased adhesion. Indeed, 
these mutants reduced adhesion below the level of the vector 
control, suggesting that they function as dominant-negative 
proteins. These data demonstrate that both a functional RA and 
PH domain are required for RIAM-supported adhesion.
Crystal structure of the RIAM  
RA-PH domains
To better understand the molecular basis for the interactions   
of RIAM with its binding partners, we determined the crystal 
structure  of  the  RA-PH  domains  of  mouse  RIAM  (residues 
149–437). Crystals of this protein were obtained in monoclinic 
space group P21 with two RIAM RA-PH molecules in the asym-
metric unit. The structure was determined by molecular replace-
ment, using the Grb10 RA-PH structure (Depetris et al., 2009; 
PDB accession no. 3HK0) as a search model. Data collection 
and refinement statistics (at 2.35 Å) are given in Table 1.
Like the corresponding domains in Grb10, the RA and PH 
domains of RIAM adopt the canonical folds of their respective 
families yet form a single structural unit through an extensive 
RA-PH domain interface, which is further fortified by inter-
actions from residues in the intervening linker region (Fig. 6 A). 
At its C terminus, the PH domain of RIAM contains a nonca-
nonical C-terminal helix, -helix 2 (2), which packs against the 
RA domain. In Grb10, this helix mediates dimerization of RA-PH 
(Depetris et al., 2009) but is not observed to do so in the RIAM 
RA-PH structure. The two molecules of RIAM RA-PH in the 
asymmetric unit of the crystal are related by a molecular twofold 
axis, but the buried surface area in this dimer is modest (1,178 Å
2), 
indicating that this dimer is probably not relevant in vivo.
Based on the crystal structures of other GTPase–RA domain 
complexes (Nassar et al., 1995; Huang et al., 1998), residues in 
and flanking 2 (Fig. 6, A and B, red) will be the primary contacts 
Functional RA and PH domains of RIAM 
are required for T cell adhesion
Having defined the binding parameters of both the RA and PH 
domains, we next sought to determine if both are required for 
stimulated lymphocyte adhesion. We transduced Jurkat T cells 
with either wild-type RIAM or RIAM with the mutations we 
defined as inhibiting the RA or PH domains. Overexpressed 
wild-type RIAM stimulated slightly basal adhesion of Jurkat   
Table 1.  X-ray data collection and refinement statistics
Variable Value
Data collection
Space group P21
Cell dimensions
 a, b, c 46.86, 82.39, and 83.40Å
 , ,   90, 95.2, and 90°
Wavelength 0.9790
Resolution 50.0–2.35Å
Rsym or Rmerge 5.9 (27.5)
a
I/I 19 (3.2)
a
Completeness 91.7% (98.3%)
a
Redundancy 2.9
Refinement
Resolution 2.35Å
No. reflections 22,885
Rwork/Rfree 23.0/27.5
Number of atoms
  Protein 4,004
  Solvent 260
B factors
  Protein 17.5
  Solvent 21.2
R.m.s deviations
  Bond lengths 0.006Å
  Bond angles 0.88°
aValues in parentheses are for the highest resolution shell (2.35–2.41 Å). One 
crystal was used for each data set. TLS (translation/libration/screw) parameters, 
one set for each protomer, were included in the refinement.
Figure 6.  Crystal structure of the RA-PH do-
mains of mouse RIAM. (A) Ribbon diagram of 
the crystal structure of RIAM RA-PH. The RA 
domain is colored yellow, the PH domain is 
colored  cyan,  and  the  intervening  linker  is 
colored gray. Residues in the RA domain that 
are predicted to interact with active GTPases 
are colored red, and the 1-2 loop in the 
PH  domain,  the  presumed  site  of  PIP  bind-
ing, is colored magenta. Secondary-structure 
elements ( helices and  strands) within the 
RA and PH domains are labeled, as are the 
N and C termini. (B) Model of the interaction 
between RIAM RA-PH and GTP-loaded Rap1. 
The model is based on the crystal structure of 
Grb14 RA-PH bound to H-Ras (not depicted). 
The same orientation and coloring as in A is 
shown, with Rap1 colored green and GTP col-
ored black and shown in stick representation. 
The figure is rendered with PyMOL.325 Membrane association of RIAM • Wynne et al.
between the RIAM RA domain and the switch 1 region of active 
Rap1. Lys213 in 1 of the RIAM RA domain is predicted to inter-
act with Asp33 of Rap1. Mutation of this lysine abrogated co-
localization of GFP-RA-PH with Rap1 at the PM (Fig. 3, C–F).
In the RIAM PH domain, 2 and the preceding 1-2 
loop contain several lysine and arginine residues (K-Xn-(K/R)-
X-R) that are likely to engage the negatively charged head-
group of PI(4,5)P2. The presence of Arg333 in 2, mutation of 
which compromises RA-PH translocation to the PM (Fig. 4 A),   
suggests that the PIP headgroup will bind canonically “atop” 
the 1-2 loop (Ceccarelli et al., 2007; Depetris et al., 2009).
Structural integration of RA and PH 
domains is required for their function
We sought to determine whether the integrated structure of the 
RIAM RA-PH domains was functionally significant. Because 
of the unlikelihood of obtaining independently folded and func-
tional RA and PH domains by mutating the domain interface 
(not depicted), we instead took the approach of engineering a 
tandem RA-PH-domain protein and abolishing domain func-
tionality individually via point mutation, effectively creating a 
“beads-on-a-string” configuration (Fig. 7 A).
GFP-2xRA-PH had higher affinity for the PM of Jurkat cells 
than did GFP-RA-PH because a significant portion of the tandem 
probe localized at the PM even in resting cells (Fig. 7 B). Co- 
expression with GTP-bound mCherry-Rap1V12 induced robust 
recruitment to the PM without any probe remaining in the cytosol 
(Fig. 7 C). Thus, the tandem probe is functional, and the higher va-
lence leads to higher avidity for the PM. Interestingly, mutation of 
both RA domains in the tandem construct resulted in a probe that 
localized to the PM in cells expressing mCherry-Rap1V12, sug-
gesting that tandem, dimeric PH domains afford sufficient affinity 
for PI(4,5)P2 to affect binding, even in the absence of an inter-
action with a GTPase (Fig. 7, D and E). In contrast, mutation of 
both PH domains yielded a probe that could not be recruited to the 
PM (Fig. 7, D and E). Expression of active H-Ras12V from a pCGN 
vector resulted in expression levels >10-fold that of mCherry-
Rap1V12 (unpublished data). Even at this level of expression,   
H-Ras12V was unable to recruit the dimeric RA domains without 
a functional PH domain. These data argue that the PH domain is 
the more important domain of the two for PM localization. When 
one RA and one PH domain were mutated so as to present one 
active copy of each domain separated from the other on the same 
polypeptide, mCherry-Rap1V12 failed to recruit the probe to 
any membrane (Fig. 7, D and E). Overexpressed H-Ras12V was   
capable of recruiting the probe, indicating that the binding domains 
were properly folded and functional. These data demonstrate 
that the structural unity of the RA and PH domains, as revealed by 
their crystal structure, is crucial for the ability of RIAM to interact 
with GTP-Rap1 and physiological levels of PI(4,5)P2 at the PM.
Figure 7.  Integrated structure of the RA-PH domains is required for PM 
association of RIAM. (A) Schematic representation of RIAM RA-PH domain 
tandem probes used in B–E. An X through a domain indicates that it has 
been inactivated by mutation (K213A for RA and K327A/K331A/R333A 
for PH). (B and C) Localization of GFP-2xRAPH expressed alone in Jurkat 
T cells (B) or with mCherry-Rap1V12 (C). (D) Localization of the indicated 
GFP-tagged tandem RA-PH probes in Jurkat T cells coexpressing mCherry-
Rap1V12 at near endogenous levels or active HrasV12 expressed 10–100-
fold above endogenous (grayscale images to right). (E) Chart summarizing 
PM recruitment. Bars: 5 µm.
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RBD itself is necessary and sufficient to drive Raf-1 to mem-
branes decorated with activated GTP-bound Ras (Chiu et al., 
2002). In contrast, our data show that the RA domain of RIAM 
is not sufficient but requires an additional contribution from a 
PH domain that is structurally integrated with the RA domain.
Our  inability  to  detect  PM  translocation  of  full-length 
GFP-tagged RIAM to the PM of Jurkat cells by live cell imag-
ing cannot be interpreted as indicating that endogenous RIAM 
does not associate with the PM. This is a common result with 
GFP-tagged, overexpressed, multidomain signaling proteins 
because when the pool that translocates is small relative to the 
vast amount that remains in the cytosol, it is difficult to score for 
PM enhancement by fluorescence. This is the case for PM re-
cruitment of the Ras effector Raf-1 (Bondeva et al., 2002; Chiu 
et al., 2002). Our analysis of endogenous RIAM by subcellular 
fractionation (Fig. 1 B) confirms that only a small portion of the 
protein stably associates with membranes in stimulated cells.
Both Ras and Rap proteins are present on multiple sub-
cellular compartments (Choy et al., 1999; Bivona et al., 2004). The 
RA domains of Raf-1 and RalGDS bind Ras and Rap, respectively, 
with relatively high affinity and have been shown to colocalize 
with the activated form of the GTPase on all membrane compart-
ments on which they are expressed (Chiu et al., 2002; Bivona 
et al., 2004). This observation has led to the recognition that 
Ras proteins signal from multiple subcellular compartments and 
that the signal output differs from each localization, providing an 
additional level of signaling complexity (Chiu et al., 2002). Our 
data show that, in contrast, signaling through RIAM is restricted to 
only one of the compartments upon which GTP-bound Rap1 accu-
mulates. The affinity of the RIAM PH domain for PI(4,5)P2, a PIP 
which is enriched only in the inner leaflet of the PM, explains the 
spatial restriction of RIAM membrane association. Whereas Raf-1 
regulates MEK/Erk kinases, which have roles both at the PM and 
in the cytoplasm (Torii et al., 2004), RIAM regulates LFA-1, which 
functions only at the PM. Thus, the spatial restriction afforded by 
combining a relatively low affinity RA domain with a PI(4,5)P2-
directed PH domain would provide efficiency by bringing RIAM 
only to the subcellular localization where it is needed.
RA domains/RBDs possess a ubiquitin fold and typically 
bind to Ras proteins through an inter-protein -sheet stabilized 
by electrostatic interactions (Emerson et al., 1995; Nassar et al., 
1995). Importantly, the binding affinities for GTP-bound GTPases 
vary widely, with Kd values that range from 80 nM for Raf-1/Ras 
to 4 µM for RIN1/Rap1 (Wohlgemuth et al., 2005). Our in vitro 
pulldown experiments (Fig. 3, A and B) show that RIAM 
RA-PH binds to GTP-loaded Rap1 or H-Ras with relatively low 
and approximately equal affinities. Previous structural and muta-
genesis studies pinpointed residue 31—Glu31 in Ras and Lys31 in 
Rap1—as a key specificity determinant in the binding of the RA 
domains of Raf-1 and RalGDS (Nassar et al., 1996). Lys84 (1) 
in the Raf-1 RA domain interacts electrostatically with Glu31 of 
Ras, and Asp56 (1-3 loop) in RalGDS interacts electrostatically 
with Lys31 of Rap1. In RIAM and the other RA-PH proteins, the 
residues corresponding to Lys84 (Raf-1) and Asp 56 (RalGDS) 
are not charged (and not conserved), providing a rationale as to 
why the RA-PH proteins are less discriminating in binding to Ras 
versus Rap1.
Discussion
Effectors of small GTPases are defined as signaling molecules 
that bind to the GTPase only when it is in the GTP-bound con-
figuration and, in so doing, affect a change that conveys signal-
ing information. The signaling information may be allosteric 
regulation of the effector, if it is an enzyme, or recruitment of the 
effector to the relevant subcellular compartment. In the case of 
RIAM, it appears that relocalization from the cytosol to the PM 
is the principle function of its RA domain. This is also true for 
the best studied Ras effector, Raf-1, which is recruited to the PM 
via its RA domain/RBD. In the case of Raf-1, it is clear that the 
Figure 8.  Model for RIAM translocation to the PM of lymphocytes. Although 
Rap1 constitutively associates with multiple cellular membranes by virtue of 
its geranylgeranyl modification, the relevant pool for LFA-1 regulation is at 
the PM where it is activated by one of two GEFs, C3G or CD-GEF1, that 
are downstream of both the TCR and chemokine receptors (A). In the resting 
state, RIAM is cytosolic and its N terminus inhibits the RA-RH membrane 
association domains. This inhibition may be alleviated by the interaction of 
talin with its binding region at the N terminus of RIAM (B). The exposed RA-
PH domain is now free to associate with the PM where the RA-PH domains 
can sense the coincidence of GTP-bound Rap1 and the constitutively high 
concentrations of PI(4,5)P2 (C). The domains are not drawn to scale. In par-
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to LFA-1 in lymphocytes must disinhibit the RIAM RA-PH 
domains. Because talin binds to the RIAM N terminus, it is 
tempting to speculate that talin binding to RIAM might accom-
plish this conformational change (Fig. 8). Because talin is also 
autoinhibited (Goksoy et al., 2008), it is possible that RIAM 
and talin work reciprocally to disinhibit each other. Because 
RIAM binds to both the inner leaflet of the PM and to the  
chain of LFA-1 (Kliche et al., 2012), our model links LFA-1 
to  talin  through  membrane-associated  RIAM,  which  would 
constitute a secondary association in addition to direct binding 
of talin to the  chain of the integrin (Tadokoro et al., 2003). 
However, this model still leaves open the question of what as-
pect of signaling enables talin binding to RIAM.
The immune system can be likened to a double-edged 
sword. On the one hand, vertebrates cannot survive without it 
in a world swarming with microbes. On the other hand, it pos-
sesses the power to destroy normal tissues. That is, there is a 
fine balance between host defense and autoimmunity. Lympho-
cyte adhesion to endothelium and APCs is absolutely required 
for adaptive immunity and therefore must be tightly controlled. 
This may explain why RIAM, a molecule which regulates lym-
phocyte adhesion, is controlled by dual membrane targeting 
domains that constitute an AND gate rather than a single deter-
minant that would represent a simple switch.
Materials and methods
Cell culture, transfection, and stimulation
Jurkat T cells were obtained from American Type Culture Collection. Cells were 
maintained in 5% CO2 at 37°C in RPMI 1640 media supplemented with 10% 
FBS. Transfection of Jurkats was performed with Lipofectamine 2000 (Invitro-
gen) according to the manufacturer’s instructions, and cells were imaged 24 h 
later. COS-1 cells (American Type Culture Collection) were maintained in 5% 
CO2 at 37°C in DME media supplemented with 10% FBS, 50 U/ml penicillin 
G, and 50 µg/ml streptomycin. Transfection of COS-1 cells was performed 
with SuperFect (QIAGEN) according to the manufacturer’s instructions. 18 h 
later, cells were either harvested for lysis or imaged live. Jurkat T cells were 
stimulated with mouse anti–human CD3 antibody (R&D Systems) at 100 ng/ml.   
COS-1 cells were stimulated with EGF (Sigma-Aldrich) at 50 ng/ml. Heter-
odimerization of FKBP12 and FRB constructs was induced by the addition of   
500 nM Rapamycin (Sigma-Aldrich). Stimulation of the AT1a receptor was ac-
complished by the addition of 1 µM angiotensin II (Sigma-Aldrich).
Stimulation, antibodies, and Western blotting
Jurkat T cells were serum starved for 4 h, treated with Wortmannin (Sigma-
Aldrich) or vehicle control for 30 min where indicated, and stimulated for   
5 min with anti–human CD3 antibody. Cells were directly lysed in 2× Laemmli 
sample buffer or subjected to subcellular fractionation (see next section). Sam-
ples were subjected to SDS-PAGE followed by immunoblotting on nitrocellulose. 
Antibodies were diluted with and blots were washed with PBST (PBS + 0.1% 
Tween 20). Analysis for RIAM and RhoGDI were performed with antibodies 
(1:1,000, Abcam; or 1:1,000, Santa Cruz Biotechnology, Inc., respectively). 
Phospho-AKT (Ser 473) was monitored by immunoblot using a phosphospe-
cific antibody (Cell Signaling Technology) at a dilution of 1:1,000. Total Erk2 
(Santa Cruz Biotechnology, Inc.) was used as a loading control (1:2,000). 
Anti-GFP (Roche) was used (1:1,000) for immunoblotting of GST pulldowns. 
Membranes were blocked with blocking buffer (LI-COR Biosciences) and blot-
ted with the indicated antibodies. Blots were developed by incubating with 
either IRDye 800CW conjugated goat anti–mouse or IRDye 680LT conjugated 
goat anti–rabbit secondary antibodies (LI-COR) used at (1:20,000). Blots were 
visualized with an Odyssey Infrared Imaging System (LI-COR Biosciences).
Cell fractionation
Jurkat T cells were resuspended in relaxation buffer (10 mM Pipes, pH 7.3, 
100 mM KCl, 3 mM NaCl, 3.5 mM MgCl2, and protease inhibitors) at a 
concentration of 10
8 cells/ml and subjected to nitrogen cavitation as we 
The crystal structure of the RIAM RA and PH domains 
shows that these two domains, separated in sequence by 50 
residues, nevertheless physically associate through a conserved 
interface to form a single structural unit. This feature was also 
observed  in  the  crystal  structure  of  the  RA-PH  domains  of 
Grb10 (Depetris et al., 2009), suggesting that it will be a general 
feature of the MRL and Grb7/10/14 protein families.
The integrated structural nature of the RA-PH domains 
(and the hydrophobic interface) suggests that they are unlikely to 
fold properly when expressed individually. This conclusion is 
supported by a recent study showing that the RA domain of 
RIAM is unstable without the PH domain (Takala and Ylänne, 
2012). These observations force a reinterpretation of results in 
published studies using the RA or PH domains expressed alone 
(Ménasché et al., 2007) and suggested that we could not readily 
express the RA and PH domains separately to parse their indi-
vidual contributions to membrane binding. To circumvent this 
problem, we expressed tandem RIAM RA-PH domains in which 
combinations of the binding motifs could be rendered nonfunc-
tional by point mutations. These experiments revealed important 
characteristics of the two membrane association domains. First, 
whereas the tandem RA domains separated by a flexible linker 
could not anchor GFP at the PM, the tandem PH domains could. 
This suggests that the added affinity and avidity of dual PH do-
mains is sufficient for binding to endogenous levels of PI(4,5)P2, 
whereas even tandem RA domains fall below the affinity thresh-
old for membranes that display activated Rap1. Besides simple 
differences in affinity, the abundance and mobility of GTP-
bound Rap1 and PI(4,5)P2 in the plane of the membrane are 
likely to be markedly different, which may contribute to the dif-
ferent relative contributions of the two binding domains.
Second, and more important, experiments with duplicate 
RA-PH domains demonstrated that the RIAM RA-PH integrated 
structural unit is more efficient at colocalizing with activated 
Rap1 than are separated RA and PH domains. Having dual mem-
brane targeting motifs constitutes a proximity detector that af-
fords a higher level of regulation than can be achieved with a 
single binding motif (Lemmon, 2008). It seems plausible that the 
evolutionary  advantage  of  the  structurally  integrated  RA-PH   
domains is that the interaction of the PH domain with membrane 
enriched in PI(4,5,)P2 spatially positions the RA domain for   
facile interaction with PM-tethered Rap1. In a beads-on-a-string 
model, with the PH domain bound to the PM, the independent 
RA domain would adopt multiple positions and orientations, 
some of which would not be compatible with Rap1 binding.
Our data clearly show that the isolated RA-PH domain of 
RIAM translocates to the lymphocyte PM much more efficiently 
than does full-length RIAM. This suggests that the RA-PH do-
mains are inhibited in full-length RIAM. Using truncation mutants, 
we mapped the autoinhibitory region to the first 57 residues that 
precede the two N-terminal coiled-coil regions. Because coiled-
coil regions are often involved in intra- and intermolecular pro-
tein–protein interactions (Mason and Arndt, 2004), which can be 
used for autoinhibition of functional domains (Rosenberg et al., 
2005),  it  is  plausible  that  hetero-  or  homo-multimerization  of 
RIAM is responsible for obscuring the RA-PH membrane-binding 
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after GFP (Bivona et al., 2004). H-Ras12V was subcloned inframe into the 
BamHI site of pcGN to produce pcGN-H-Ras12V. Rap1 and Rap1V12 were 
subcloned inframe into pmCherry-C1 (Takara Bio Inc.). cDNA for mouse 
RIAM (obtained from G. Koretzky, University of Pennsylvania, Philadelphia, 
PA) was used as a PCR template to produce full-length RIAM and truncations 
of RIAM that were then cloned into either pEGFP-C1 or pEGFP-N1 vectors 
(Takara Bio Inc.). Point mutations were made with the QuikChange XL Site-
Directed mutagenesis kit (Agilent Technologies). Tandem RA-PH constructs 
were constructed by sequential cloning of RA-PH into pEGFP-C1. First, an 
RA-PH construct was cloned into the MCS with EcoR1 and Apa1. A second 
RA-PH construct was then cloned in with Apa1 and BamH1. A 5-aa linker 
encoded by the Apa1 site separates the RA-PH constructs. RFP-FKBP12-5-
Ptase, RFP-FKBP12, PM-FRB-CFP, and Rat AT1a (gifts of T. Balla, National In-
stitute of Child Health & Human Development, Bethesda, MD) and were 
previously described (Varnai et al., 2006). RFP-FKBP12 consists of RFP fused 
to  human  FKBP12.  RFP-FKBP12-5-Ptase  consists  of  RFP  fused  to  human 
FKBP12 followed by 5-phosphatase domain (aa 214–644) of human type IV 
5-phosphatase. PM-FRB-CFP consists of the N-terminal localization sequence 
of GAP43 (aa 1–20) fused to the FRB domain of mTOR1 (aa 2019–2114) 
which is also fused to CFP. Rat AT1a was expressed from pcDNA6 myc/his 
with a C-terminal myc/his tag. PH-PLC-GFP (gift of S. Grinstein, Hospital for 
Sick Children, Toronto, Ontario, Canada) consists of the PH domain from 
human phospholipase C delta 1 (aa 1–170) fused to GFP. FLAG-Rap1GAP 
(gift from L. Quilliam, Indiana University School of Medicine, Indianapolis, 
IN) consists of human Rap1GAP fused to an N-terminal FLAG sequence. All 
plasmids were verified with bidirectional sequencing.
Protein expression and purification
We generated a 6xHis-tagged RIAM construct by subcloning cDNA encod-
ing residues 149–437 (RA and PH domains) of mouse RIAM into a modi-
fied expression vector pET28a (Novagen). We verified the construct by 
DNA  sequencing.  We  transformed  this  construct  into  E.  coli  strain 
Rosetta2(DE3) (Novagen), and we grew cultures in Luria broth media at 
37°C and induced with 0.4 mM (IPTG) at 20°C. We harvested the cells 
and resuspended them in lysis buffer (20 mM Tris, pH 8.0, and 500 mM 
NaCl), lysed them by homogenizer, and clarified by centrifugation. We 
isolated the 6xHis-tagged protein by Ni
2+-affinity chromatography, cleaved 
with TEV protease to remove the tag, and further purified the protein by 
ion-exchange chromatography (Source S; GE Healthcare). The purified 
protein included RIAM residues 149–437 and three heterologous residues 
(GHM) on the N terminus remaining from the TEV protease cleavage site.
X-ray crystallography
We concentrated RIAM RA-PH to 10 mg ml
1 and grew crystals at 17°C in 
hanging drops containing equal volumes of protein solution and reservoir 
buffer (12% wt/vol PEG3350, 100 mM LiAc). Crystals of RIAM RA-PH be-
long to space group P21. There are two RIAM RA-PH molecules in the asym-
metric unit (solvent content, 47.4%). We equilibrated crystals in a stabilizing 
solution containing reservoir buffer plus 20% (vol/vol) ethylene glycol. We 
collected data from one crystal on beam line X4A at the National Synchrotron 
Light Source, Brookhaven National Laboratory. We processed diffraction 
data using HKL2000 (Otwinowski and Minor, 1997) and determined the 
RIAM RA-PH structure by molecular replacement using the Grb10 RA-PH struc-
ture (Depetris et al., 2009; PDB accession no. 3HK0) as the search model. 
We performed model building with Coot (Emsley and Cowtan, 2004) and 
refined the structure (at 2.35 Å) using REFMAC (Murshudov et al., 1997). The 
final atomic model contains residues 178–437, excluding 279–292 (chain 
A), and residues 179–278, excluding 279–292 (chain B).
Phosphoinositide binding measurements
We mixed purified RIAM RA-PH at concentrations ranging from 0.8 µM 
to 50 µM, or buffer only, with 12.5 nM (final) BODIPY TMR-labeled phos-
phoinositides (Echelon) in a buffer containing 20 mM HEPES, pH 7.5, 
150 mM NaCl, and 0.05% (vol/vol) Tween-20. After 5 min of incuba-
tion, we added 20 µl of the reaction mix to individual wells of a 384-well 
assay plate (Corning) and then measured fluorescence polarization at 
room temperature using a plate reader (Infinite F500; TECAN). We used 
a 535/25 nm filter as an excitation filter, and a pair of 590/20 nm filters 
as emission polarization filters. We subtracted the buffer-only data from 
the protein data and performed curve fitting to a single-site (saturating) 
binding model using SigmaPlot (Systat Software).
Accession Nos.
Atomic coordinates and structure factors for RIAM RA-PH have been de-
posited in the Protein Data Bank under the accession number 3TCA.
have previously described (Mor et al., 2009). In brief, the cell suspension 
was equilibrated with N2 at 350 psi for 20 min at 4°C in a nitrogen bomb 
(Parr Instrument Company). Dropwise release from the bomb resulted in 
disruption of the cells by cavitation. The cavitate was collected into a tube 
containing EDTA to a final concentration of 1 mM and centrifuged at 500 g  
for 10 min to remove unbroken cells and nuclei. Postnuclear supernatants 
were separated into membrane and cytosolic fractions by centrifugation at 
175,000 g for 45 min at 4°C. Equal cells equivalents of each fraction 
were analyzed by SDS-PAGE and immunoblot.
Microscopy
Live cells were plated in 35-mm dishes containing a no. 0 glass coverslip 
over a 15-mm cutout (MatTek Corporation). COS-1 cells were plated and 
subsequently transfected in MatTek dishes. Jurkat T cells were transfected in 
suspension and plated on poly-lysine–coated MatTek dishes before imaging. 
COS-1 cells and Jurkat T cells were imaged in DME media and RPMI 1640 
media, respectively. Cells were imaged at 37°C with an inverted laser-
scanning confocal microscope (510 Meta; Carl Zeiss) equipped with   
a Plan-Apochromat 63×/1.40 oil DIC objective. Images were acquired 
with Zen 2008 software (Carl Zeiss) and were processed with Photoshop 
CS4 (Adobe).
Cell adhesion assay
10
6 Jurkat cells were resuspended in 0.4 ml RPMI-1640 medium supplemented 
with 10% FCS (RPMI-10) and transfected with 50 µg of plasmid DNA encod-
ing various RIAM constructs using an electroporator (Bio-Rad Laboratories) 
with a 4-mm cuvette and exponential decay pulse set at 250 V, 975 µF, 400 
Ohms. The cells were then allowed to recover for 48 h. 96-well flat-bottom 
MaxiSorp plates (Thermo Fisher Scientific) were coated overnight at 4°C with 
10 µg/ml goat anti–human IgG (Jackson ImmunoResearch Laboratories), fol-
lowed by coating with 1 µg/ml human recombinant ICAM-1/Fc chimera (R&D 
Systems) or 2% BSA (Sigma-Aldrich) for 1 h at 37°C. Jurkat cells were har-
vested 48 h after transfection and resuspended as 0.2 × 10
6/ml in warm PBS 
and labeled with 1 µM BCECF (Molecular Probes) for 30 min at 37°C, washed 
in PBS, and resuspended in prewarmed RPMI-10. Cells where then stimulated 
with either 5 µg/ml anti-CD3 mAbs (Fitzgerald Industries) or with 100 ng/ml 
PMA for 30 min at 37°C, and then cells were plated in triplicates (100,000 
cells/well) and incubated for 1 h at 37°C. Total fluorescence input (Ex494/
Em517nm) was determined using a plate reader (SpectraMax M5; Molecular 
Devices). Unbound cells were removed by washing the plate with warm 0.2% 
BSA in PBS. Adherence was calculated as emission of bound cells divided by 
emission of total cells seeded per well.
GST pulldowns
Full-length Rap1b or H-Ras was cloned into pGEX-2T. The resulting plasmids 
were used to transform BL21 DE3 E. coli. Cultures were grown at room tem-
perature and allowed to reach an OD600 of 0.6 before being induced with 
1 mM isopropyl-thiogalactopyranoside (IPTG) overnight. Cultures were har-
vested by centrifugation at 6,000 g for 15 min. The cell pellet was resus-
pended in bacterial lysis buffer (0.5% Triton X-100, 50 mM Tris-Cl, pH 8.0, 
and 50 mM EDTA) to which a fresh 5 mM DTT and complete protease inhibitor 
cocktail (Roche) was added. Cells were lysed by the addition of 25 mg lyso-
zyme and allowed to incubate on ice for 20 min. Cells were further disrupted 
by sonication. The lysed cells were then centrifuged at 20,000 g for 30 min. 
The  supernatant  was  collected  and  incubated  with  glutathione-conjugated 
agarose beads for 60 min at 4°C with gentle agitation. Beads were washed 
3× with bacterial wash buffer (0.5% Triton X-100, 20 mM Tris-Cl, pH 8.0, and 
500 mM NaCl), and then once with PBS and stored in PBS with protease in-
hibitor. SDS-PAGE and Coomassie staining were used to determine yield and 
purity. Nucleotide loading was accomplished by incubating 100 µl GST-Rap1 
or GST-H-Ras beads in PBS supplemented with 25 mM EDTA and 0.5 mM 
GTPS or GDPS (Sigma-Aldrich) and allowing it to incubate at room temper-
ature for 15 min. 10 µl of 1 M MgCl2 was added to the reaction and incu-
bated  at  room  temperature  for  an  additional  10  min.  COS-1  cells  were 
transfected with the indicated GFP-RIAM construct with Superfect. Cells were 
lysed 18 h later by the addition of lysis buffer (1% Triton X-100, 20 mM Tris-
HCl, pH 7.5, 150 mM NaCl, and 10 mM MgCl2) supplemented with prote-
ase  inhibitor  cocktail.  Cleared  lysates  were  divided  and  incubated  with 
nucleotide-loaded GST-Rap1 or GST-H-Ras for 40 min at 4°C with gentle agita-
tion. Beads were centrifuged at 600 g for 2 min and washed 2× with lysis buf-
fer. Samples were then boiled in 2× Laemmli sample buffer and subjected to 
SDS-PAGE followed by immunoblot analysis with anti-GFP antibodies.
Plasmids
The production of pEGFP-RalGDS-RBD was previously described and con-
sists of the RBD domain of human RalGDS (aa 787–884) cloned into frame 329 Membrane association of RIAM • Wynne et al.
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